HRA009827
Title:
CAR-T cells eradicating CD19+/BCMA+ autoantibody-producing clones for SLE treatment
Release date:
2025-07-25
Description:
CD19 and BCMA CAR-T cells are safe for the treatment of SLE patients and can achieve immune reset through deep and comprehensive clearance of pathogenic antibody-secreting cells, resulting in sustained drug-free remission.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
systemic lupus erythematosus
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
autoimmune diseases data
Contact person:
Huang He
Email:
huanghe@zju.edu.cn
Description:
scRNA-seq and BCR data from SLE patients
Individuals & samples
Submitter:   Huang He / huanghe@zju.edu.cn
Organization:   The First Affiliated Hospital, Zhejiang University School of Medicine
Submission date:   2024-12-24
Requests:   11